LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovation Leadership Chimeric Therapeutics is a pioneering cell therapy biotech company in Australia with recent FDA clearance for a novel CAR T therapy, indicating a strong focus on cutting-edge treatments and potential collaborations with organizations seeking advanced cell therapy solutions.

Strategic Partnerships The company's recent collaborations with Viral Vector Manufacturing facilities and Cell Therapies Pty Ltd suggest opportunities to offer specialized manufacturing, clinical development support, or joint research initiatives to enhance their therapy pipeline.

Funding & Growth Chimeric has secured substantial recent funding, including a $10M investment from Lind Global and a $2.5M R&D financing, highlighting their growth trajectory and opening avenues for sales of research services, biotech infrastructure tools, or therapeutic adjuncts.

Market Presence The company's active engagement in industry events like the NWR Virtual Healthcare Conference indicates they value visibility and networking, presenting opportunities to pitch innovative biotech solutions, conference sponsorships, or strategic alliances.

Research & Development Focus With its emphasis on novel cell therapies such as CHM CDH17 and CHM 2101, Chimeric is a prime candidate for suppliers of GMP-grade viral vectors, specialized lab equipment, or clinical trial support services tailored to advanced cell therapy development.

Similar companies to Chimeric Therapeutics

Chimeric Therapeutics Tech Stack

Chimeric Therapeutics uses 8 technology products and services including Webpack, Microsoft 365, React, and more. Explore Chimeric Therapeutics's tech stack below.

  • Webpack
    Development
  • Microsoft 365
    Email
  • React
    Javascript Frameworks
  • Vue.js
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Amazon ALB
    Load Balancers
  • Gravity Forms
    Web Platform Extensions

Chimeric Therapeutics's Email Address Formats

Chimeric Therapeutics uses at least 1 format(s):
Chimeric Therapeutics Email FormatsExamplePercentage
FLast@chimerictherapeutics.comJDoe@chimerictherapeutics.com
81%
LastFir@chimerictherapeutics.comDoeJoh@chimerictherapeutics.com
7%
Last_First@chimerictherapeutics.comDoe_John@chimerictherapeutics.com
8%
First-Last@chimerictherapeutics.comJohn-Doe@chimerictherapeutics.com
4%

Frequently Asked Questions

Where is Chimeric Therapeutics's headquarters located?

Minus sign iconPlus sign iconChimeric Therapeutics's main headquarters is located at 62 Lygon St, LEVEL 3 Carlton, Victoria 3053, AU. The company has employees across 2 continents, including North AmericaOceania.

What is Chimeric Therapeutics's official website and social media links?

Minus sign iconPlus sign iconChimeric Therapeutics's official website is chimerictherapeutics.com and has social profiles on LinkedIn.

What is Chimeric Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconChimeric Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Chimeric Therapeutics have currently?

Minus sign iconPlus sign iconAs of October 2025, Chimeric Therapeutics has approximately 9 employees across 2 continents, including North AmericaOceania. Key team members include Chief Executive Officer: R. M.Executive Director, Cmc: A. B.. Explore Chimeric Therapeutics's employee directory with LeadIQ.

What industry does Chimeric Therapeutics belong to?

Minus sign iconPlus sign iconChimeric Therapeutics operates in the Biotechnology Research industry.

What technology does Chimeric Therapeutics use?

Minus sign iconPlus sign iconChimeric Therapeutics's tech stack includes WebpackMicrosoft 365ReactVue.jsjQueryModernizrAmazon ALBGravity Forms.

What is Chimeric Therapeutics's email format?

Minus sign iconPlus sign iconChimeric Therapeutics's email format typically follows the pattern of FLast@chimerictherapeutics.com. Find more Chimeric Therapeutics email formats with LeadIQ.

When was Chimeric Therapeutics founded?

Minus sign iconPlus sign iconChimeric Therapeutics was founded in 2020.
Chimeric Therapeutics

Chimeric Therapeutics

Biotechnology ResearchAustralia2-10 Employees

Chimeric Therapeutics is the ASX leader in cell therapy.

As the only clinical stage, cell therapy biotechnology company in Australia, our focus is on discovering, developing and commercialising novel cell therapies with the most potential for patients.

ASX: CHM

Section iconCompany Overview

Headquarters
62 Lygon St, LEVEL 3 Carlton, Victoria 3053, AU
Website
chimerictherapeutics.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Chimeric Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Chimeric Therapeutics's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    R. M.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. B.
    Executive Director, Cmc
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.